Beam Therapeutics Inc (BEAM) is destined for greater heights as its last quarter sales were 30,070 K
A new trading day began on Friday, with Beam Therapeutics Inc (NASDAQ: BEAM) stock price down -3.22% from the previous day of trading, before settling